Table 4.
Detection rate per 1000 screened women with the 75.7% uptake of 2019 (reference scenario) and the 39.2% uptake of 2020.
| Detection rate /1000 (95% CI) |
|||
|---|---|---|---|
| Uptake 2019 (75.7%)1 | Uptake 2020 (39.2%)1 | ||
| Age group | 50–54 | 3.4 (2.6–4.6) | 3.6 (2.5–5.0) |
| 55–59 | 4.0 (3.2–5.0) | 4.4 (3.3–5.7) | |
| 60–64 | 4.8 (3.8–5.8) | 5.2 (4.0–6.8) | |
| 65–69 | 5.9 (5.0–7.7) | 6.6 (5.4–8.6) | |
| 70–74 | 5.9 (4.5–7.4) | 6.8 (4.8–9.2) | |
| Tumour size | < 2 cm | 3.7 (3.1–4.4) | 3.8 (3.1–4.7) |
| 2–5 cm | 0.93 (0.86–0.97) | 1.21 (1.05–1.41) | |
| > 5 cm | 0.05 (0.04–0.05) | 0.09 (0.08–0.11) | |
| Interval cancer rate | 2.0 (1.7–2.2) | 5.1 (4.7–5.4) | |
| False positives | 34.7 (29.7–39.7) | 34.5 (29.5–39.4) | |
1
Data IKNL (2021).